Početna stranicaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
219,61 $
Poslije radnog vremena:(0,00 %)0,00
219,61 $
Zatvoreno: 23. sij, 17:07:01 GMT -5 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
224,03 $
Dnevni raspon
217,57 $ - 223,20 $
Godišnji raspon
91,86 $ - 228,88 $
Tržišna kapitalizacija
10,81 mlr. USD
Prosječna količina
699,77 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
NYSE
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (USD) | ruj 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 1,00 mlr. | −0,49 % |
Operativni troškovi | 201,05 mil. | −8,50 % |
Neto dohodak | 54,42 mil. | −21,87 % |
Neto profitabilnost | 5,42 | −21,45 % |
Zarada po dionici | 2,43 | −6,18 % |
EBITDA | 165,25 mil. | −30,05 % |
Efektivna porezna stopa | 36,29 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (USD) | ruj 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 207,10 mil. | −1,46 % |
Ukupna imovina | 7,51 mlr. | −6,12 % |
Ukupne obveze | 4,06 mlr. | −2,71 % |
Ukupni kapital | 3,45 mlr. | — |
Dionice u optjecaju | 49,22 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 3,24 | — |
Povrat imovine | 5,01 % | — |
Povrat kapitala | 6,16 % | — |
Tok novca
Neto promjena novca
| (USD) | ruj 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 54,42 mil. | −21,87 % |
Gotovina od poslovanja | 213,83 mil. | −15,08 % |
Gotovina iz ulaganja | −33,70 mil. | −58,02 % |
Gotovina iz financiranja | −152,62 mil. | 26,46 % |
Neto promjena novca | 24,48 mil. | −20,09 % |
Slobodan tok novca | 60,91 mil. | −72,72 % |
Više
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Glavni izvršni direktor
Osnovano
1947
Web-lokacija
Zaposlenici
19.400